Evidence map›Paper›PMID 23716979›Full record

ReviewWorld journal of gastroenterology2013

Colon cancer stem cells: controversies and perspectives.

Maria Ausiliatrice Puglisi, Valentina Tesori, Wanda Lattanzi, Giovanni Battista Gasbarrini, Antonio Gasbarrini

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Prognostic impact of cancer stem cell markersAmerican journal of translational research · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Ausiliatrice PuglisiDepartment of Internal Medicine and Gastroenterology, Gemelli Hospital, 00168 Rome, Italy. Italy. ausiliapuglisi@yahoo.it
Valentina Tesori
Wanda Lattanzi
Giovanni Battista Gasbarrini
Antonio Gasbarrini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumors have long been viewed as a population in which all cells have the equal propensity to form new tumors, the so called conventional stochastic model. The cutting-edge theory on tumor origin and progression, tends to consider cancer as a stem cell disease. Stem cells are actively involved in the onset and maintenance of colon cancer. This review is intended to examine the state of the art on colon cancer stem cells (CSCs), with regard to the recent achievements of basic research and to the corresponding translational consequences. Specific prominence is given to the hypothesized origin of CSCs and to the methods for their identification. The growing understanding of CSC biology is driving the optimization of novel anti-cancer targeted drugs.

Indexed as

AnimalsAntineoplastic AgentsBiomarkers, TumorCell DifferentiationCell LineageCell ProliferationCell Transformation, NeoplasticColonic NeoplasmsHumansMolecular Targeted TherapyNeoplastic Stem CellsSignal TransductionAntineoplastic AgentsBiomarkers, TumorCD133ChemoresistanceColon cancer stem cellsColorectal cancerTherapy

Identifiers

PMID23716979
PMCPMC3662939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.